Trial reportThe oncologist2019
Pediatric NUT Carcinoma Is a Rare and Challenging Tumor: Single Center Experience of Five Children.
Trial report in The oncologist, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.
- Radiological features of sinonasal NUT (nuclear protein in testis) carcinoma: case series and systematic review.Japanese journal of radiology · 2026Pooled it
- Pediatric NUT carcinoma: a patient series and literature review.BMC pediatrics · 2025Review
- Metastatic NUT Carcinoma in a Child.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023Article
- The expanding universe of NUTM1 fusions in pediatric cancer.Clinical and translational science · 2023Review
- Clinicopathological molecular characterizations of sinonasal NUT carcinoma: a report of two cases and a literature review.Frontiers in oncology · 2023Article
- Complete Response Induced by Concurrent Chemoradiotherapy in a Patient with NUT Carcinoma.Internal medicine (Tokyo, Japan) · 2022Article
- NUT Carcinoma-An Underdiagnosed Malignancy.Frontiers in oncology · 2022Review
- Skin adnexal carcinoma with BRD3-NUTM2B fusion.Journal of cutaneous pathology · 2021Article
- Nuclear protein in testis midline carcinoma in a Turkish boy: a case report.Asian biomedicine : research, reviews and news · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNuclear protein of the testis (NUT) carcinoma is a rare and aggressive malignancy associated with rearrangements of the nuclear protein of the testis (NUT) gene on chromosome 15q14. Because of its rarity, this tumor is often underdiagnosed and underreported, and there is limited literature regarding its biology and optimal management. METHODS AND
resultsWe report our experience of five patients with pediatric NUT carcinoma, all of whom presented with midline head and neck mass. In spite of aggressive multimodality treatment, only one patient survives.
conclusionNUT carcinoma has a dismal prognosis in spite of aggressive multimodality management (surgery and adjuvant chemotherapy and/or radiation). Novel strategies are required to improve outcomes of patients with this tumor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.